Cost-effectiveness of cervical cancer screening and HPV vaccination: a Markov model from the healthcare payer perspective
Within the current resource and policy context, combining HPV testing with the 9-valent vaccine provides the highest economic value. This strategy offers evidence to guide future cervical cancer prevention policies in southern China.
Authors
- Kang Jiang (ORCID: https://orcid.org/0000-0002-0884-1651)
- Hongxin Huang (ORCID: https://orcid.org/0000-0002-8656-4266)
- Xiao‐Jun Huang (ORCID: https://orcid.org/0000-0002-2145-6643)
- Weixia Liu
- Jing Li (ORCID: https://orcid.org/0000-0003-4072-4102)
- Wei Lü (ORCID: https://orcid.org/0000-0003-4043-6047)
Institutions
- Hainan University (CN)
- Hainan Medical University (CN)
Publication Details
- Journal
- Frontiers in Public Health
- Published
- 2025-10-21
- DOI
- https://doi.org/10.3389/fpubh.2025.1508623
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Hainan Medical University